<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="editorial" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2023.1361884</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Editorial</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Editorial: Environmental factors in autoimmunity</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Dunn</surname>
<given-names>Shannon E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/998018"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Correale</surname>
<given-names>Jorge</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/31679"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gommerman</surname>
<given-names>Jennifer L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/24422"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Horwitz</surname>
<given-names>Marc S.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/212508"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Immunology, University of Toronto</institution>, <addr-line>Toronto, ON</addr-line>, <country>Canada</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Institute of Biological Chemistry and Physiocochemistry, School of Pharmacy and Biochemistry, University of Buenos Aires</institution>, <addr-line>Buenos Aires</addr-line>, <country>Argentina</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Microbiology and Immunology, University of British Columbia</institution>, <addr-line>Vancouver, BC</addr-line>, <country>Canada</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited and Reviewed by: Betty Diamond, Feinstein Institute for Medical Research, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Shannon E. Dunn, <email xlink:href="mailto:shannon.dunn@utoronto.ca">shannon.dunn@utoronto.ca</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>01</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1361884</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>12</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>12</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Dunn, Correale, Gommerman and Horwitz</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Dunn, Correale, Gommerman and Horwitz</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<related-article id="RA1" related-article-type="commentary-article" xlink:href="https://www.frontiersin.org/research-topics/36433" ext-link-type="uri">Editorial on the Research Topic <article-title>Environmental factors in autoimmunity</article-title>
</related-article>
<kwd-group>
<kwd>environmental factors</kwd>
<kwd>autoimmunity</kwd>
<kwd>microbiome</kwd>
<kwd>diet</kwd>
<kwd>viruses</kwd>
</kwd-group>
<counts>
<fig-count count="0"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="11"/>
<page-count count="3"/>
<word-count count="1545"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<p>While the T and B lymphocyte repertoires are designed to be able to recognize foreign antigen (pathogens) to protect the host, significant portions of these repertoires can recognize self-antigens. Normally this is not a problem for the host because such autoreactive lymphocytes are removed (clonal deletion), redeemed by B cell receptor (BCR) editing, anergized, or actively suppressed in the periphery by regulatory T and B cells (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). Despite these mechanisms, an estimated 7-9% of humans are diagnosed with an autoimmune disease (<xref ref-type="bibr" rid="B3">3</xref>). Puzzlingly, an equal percentage of healthy people have autoreactive anti-nuclear antibodies in their blood despite having no clinical evidence of autoimmunity (<xref ref-type="bibr" rid="B4">4</xref>). Classic studies that reported on the concordance of autoimmunity in monozygotic and dizygotic twins indicated that a large fraction of autoimmune risk (&gt;50%) is conferred by environmental factors that interact with genetic factors to initiate disease (<xref ref-type="bibr" rid="B5">5</xref>). Thus, autoimmunity may be largely preventable if the specific causal environmental factors are identified, as seminal studies have shown that initial autoimmune pathogenic events take place prior to clinical manifestations.</p>
<p>This Research Topic aimed to provide new insights into environmental risk factors in autoimmunity and includes reviews and articles that describe how dietary factors and obesity, maternal and early life factors, viruses, the microbiome, and inhaled environmental toxins influence the development of autoimmunity.</p>
<sec id="s1">
<title>Dietary factors and obesity in autoimmunity</title>
<p>Past studies have identified obesity as a common risk factor for many autoimmune diseases including multiple sclerosis (MS), systemic autoimmune erythematosus (SLE), and Alopecia Areata (AA) (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1147447">Touil et&#xa0;al.</ext-link>; <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2022.1038393">Correale and Marrodan</ext-link>). <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2022.1038393">Correale and Marrodan</ext-link> reviewed how the adipose tissue becomes inflamed with obesity and how this leads to the development of pro-inflammatory adipokine production that can enhance neuroimmune mechanisms in MS and in animal models of MS. <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1147447">Touil et&#xa0;al.</ext-link> added to this theme by reviewing how other lifestyle factors including diet quality and dietary deficiencies potentially contribute to autoimmunity development. The general conclusion from this review was that consumption of a diet rich in vegetables, dietary fibers, and polyunsaturated fatty acids (including fish oils) and low in saturated fat is protective against autoimmunity. This review also cited that deficiencies in vitamin D and folate are common in autoimmune disease.</p>
<p>A difficulty with interpreting association studies is the possibility of reverse causality&#x2013;that the disease modulates exposure to the environmental factor. Mendelian randomization (MR) is a genetic approach whereby the presence of small nucleotide polymorphisms (SNPs) that associate with environmental exposure are compared between disease cases and controls. Since inheritance of the SNP influences biology from conception, causality can be inferred in this analysis. Using MR, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1139799">Yang et&#xa0;al.</ext-link> found that genetically-predicted folate levels inversely associated with development of the autoimmune skin disease Vitiligo (odds ratio=0.47, P=1.3 x 10<sup>-4</sup>), but not with development of inflammatory bowel disease (IBD), rheumatoid arthritis, or SLE. This finding will direct future efforts to unravel the biological mechanisms of how folate is protective against autoimmunity in Vitiligo.</p>
<p>As overviewed by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1188750">Bugbee et&#xa0;al.</ext-link>, dietary factors can also modulate the microbiome to shift the immune system towards a state of tolerance through activation of the IL-10 receptor, a key cytokine signaling pathway that for the most part down-regulates inflammation, but with some important (and puzzling) exceptions. Alternatively, the diet can provide a source of epitopes that can sustain cross-reactive autoreactive T and B cell responses. Specifically, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1202006">Chunder et&#xa0;al.</ext-link> discussed how MS patients have greater IgG reactivities to bovine and goat milk compared to healthy controls: greater IgG reactivities were not present against sheep or plant-based milk in MS patients. IgG antibodies enriched in MS were reactive against the milk proteins casein and &#x3b2;-lactoglobulin; those patients having the highest reactivities to &#x3b2;-casein exhibited the highest disability scores. Past work by this group demonstrated molecular mimicry between casein and the myelin antigen protein, myelin-associated glycoprotein (<xref ref-type="bibr" rid="B6">6</xref>). Together these findings raise the prospect that anti-milk IgGs may be pathogenic in MS and that plant-based milk products could be novel dietary interventions for this disease.</p>
</sec>
<sec id="s2">
<title>Exposure to mercury and other inhaled pollutants and autoimmunity</title>
<p>Kawasaki disease (KD) is an autoimmune/autoinflammatory disease that involves activation of the inflammasome and targets the coronary arteries in children. Past studies have described &#x201c;outbreaks&#x201d; of KD in Japan in years when wind-patterns shifted, bringing more pollutants from China (<xref ref-type="bibr" rid="B7">7</xref>). Intrigued by this and case reports of KD developing in response to exposure to mercury vapors (<xref ref-type="bibr" rid="B8">8</xref>), <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1126154">Alphonse et&#xa0;al.</ext-link> examined the effect of mercury on inflammasome activation in the presence of <italic>Lactobacillus</italic> cell wall extract (LCWE), which is a factor that can induce KD-like disease in mice. They found that mercuric chloride raised calcium levels in bone-marrow derived DCs, providing signal 2 for NLRP3 inflammasome activation in these cells. Furthermore co-administration of mercuric chloride with LCWE markedly increased serum levels of pro-inflammatory cytokines IL-1 and IL-18 and enhanced the incidence and severity of coronary arteritis in mice. These findings provide proof of concept that mercury may be an environmental contributor to KD.</p>
<p>Inhalation of silicon dioxide (cSiO<sub>2</sub>) and cigarette smoke has been linked to the development of SLE and MS (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1147447">Touil et&#xa0;al.</ext-link>; <xref ref-type="bibr" rid="B9">9</xref>). In this Research Topic, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2022.972108">Heine et&#xa0;al.</ext-link> demonstrated that intranasal instillation of cSiO<sub>2</sub> in lupus prone, New Zealand Black/White F1 (NZB/W F1) mice induced the development of ectopic lymphoid structures (ELS) in the lung and accelerated the development of lupus nephritis. Provision of clinically-relevant doses of prednisone in the diet reduced cSiO<sub>2</sub>-induced pulmonary ELS formation, nuclear-specific autoantibody production, and glomerulonephritis, but did not increase animal survival due to treatment-associated toxicity. These experiments highlight a role of lung inflammation in SLE and cSiO<sub>2</sub>-accelerated SLE as a model for testing existing and novel therapies for SLE.</p>
</sec>
<sec id="s3">
<title>Microbiome and viruses in autoimmunity</title>
<p>Articles in this Research Topic also reported on the role of viruses and the microbiome in the development of autoimmunity. A review by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1146082">Strauchan et&#xa0;al.</ext-link> investigated how maternal factors such as the maternal microbiome, breast-milk-derived autoantibodies may protect against the development of type I diabetes (TID), whereas, an article by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2022.1033393">Yue et&#xa0;al.</ext-link> described how the host genotype, specifically a high-risk major histocompatibility haplotype can shape the microbiome and serum metabolites in TID patients. Another MR study addressed the bi-directional relationship between genetic SNPs predictive of IBD and the development of herpesvirus-associated diseases, chicken pox, herpes zoster and mononucleosis. Despite prior case control studies that reported associations between these infectious diseases caused by varicella-zoster virus and Epstein Barr virus (EBV) and IBD, this MR study did not find a causal association. The authors did find that IBD-associated SNPs predicted mononucleosis, thereby suggesting that genes that are associated with autoimmunity may predispose to a more pro-inflammatory manifestation of EBV infection.</p>
<p>Enteroviruses, including coxsackieviruses are over-represented in children that progress to develop TID and coxsackievirus infection has been shown to accelerate the development of TID in both female and male non-obese diabetic (NOD) mice (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B11">11</xref>). Here, an article by <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1096323">Morse et&#xa0;al.</ext-link>, described how coxsacksackievirus B4 (CVB4) alters the microbiome and host-barrier function to accelerate TID in NOD mice. CVB4 infection induced rapid microbiome changes, erosion of the mucosal barrier, and increased gut bacterial translocation to the pancreatic lymph node. Transfer of fecal matter from CVB4-infected NOD mice increased the development of TID in female, but not male antibiotic-depleted NOD recipients. This increase was associated with reduced short chain fatty acid receptor expression and decreased IL-10-producing regulatory cells in the gut, suggesting the development of a less tolerogenic gut immune profile. These results provide insights into how enteroviruses may induce the development of TID and revealed a key sex difference in virus-mediated T1D development in mice.</p>
</sec>
<sec id="s4">
<title>The immunoglobulin repertoire in endemic phemphigus foliaceus</title>
<p>Phemphigus foliaceus (PF) is an autoimmune disease that is characterized by development of autoantibodies against desmoglein-1 that disrupt adhesion between the upper layers of the skin and induce skin blistering. Although a very rare condition, in certain areas in Brazil it is endemic and can affect ~3% of the population (<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1189251">Calonga-Solis et&#xa0;al.</ext-link>). To address the molecular basis of this endemic autoimmunity, <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fimmu.2023.1189251">Calonga-Solis et&#xa0;al.</ext-link> sequenced the B cell receptor heavy chain and the variable regions of IgM and IgG of a limited number of PF patients and controls within the endemic region as well as controls from outside of the endemic region. Remarkably, both patients and controls living within the endemic region showed dramatically lower clonotype diversity suggesting that the immune system of these individuals is subject to intense environmental pressure. Compared to controls in the endemic region, BCRs of PF patients had increased IGHV3-30 usage and unique clusters of CDR3 sequences that may comprise the autoreactive B cell population. Future studies could use these cloned BCR sequences to identify the environmental trigger in endemic PF.</p>
<p>Overall, our Research Topic revealed new insights into the causal relationships and molecular mechanisms of how environmental factors can trigger autoimmunity.</p>
</sec>
<sec id="s5" sec-type="author-contributions">
<title>Author contributions</title>
<p>SD: Conceptualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. JC: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. JG: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing. MH: Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s6" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s7" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shlomchik</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>Sites and stages of autoreactive B cell activation and regulation</article-title>. <source>Immunity</source> (<year>2008</year>) <volume>28</volume>:<fpage>18</fpage>&#x2013;<lpage>28</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2007.12.004</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xing</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Hogquist</surname> <given-names>KA</given-names>
</name>
</person-group>. <article-title>T-cell tolerance: central and peripheral</article-title>. <source>Cold Spring Harb Perspect Biol</source> (<year>2012</year>) <volume>4</volume>(<issue>6</issue>): <elocation-id>a006957</elocation-id>. doi: <pub-id pub-id-type="doi">10.1101/cshperspect.a006957</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname> <given-names>GS</given-names>
</name>
<name>
<surname>Bynum</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Somers</surname> <given-names>EC</given-names>
</name>
</person-group>. <article-title>Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases</article-title>. <source>J Autoimmun</source> (<year>2009</year>) <volume>33</volume>:<fpage>197</fpage>&#x2013;<lpage>207</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jaut.2009.09.008</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Slight-Webb</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Ritterhouse</surname> <given-names>LL</given-names>
</name>
<name>
<surname>Munroe</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Maecker</surname> <given-names>HT</given-names>
</name>
<name>
<surname>Fathman</surname> <given-names>CG</given-names>
</name>
<etal/>
</person-group>. <article-title>Autoantibody-positive healthy individuals display unique immune profiles that may regulate autoimmunity</article-title>. <source>Arthritis Rheumatol</source> (<year>2016</year>) <volume>68</volume>:<page-range>2492&#x2013;502</page-range>. doi: <pub-id pub-id-type="doi">10.1002/art.39706</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castillo-Fernandez</surname> <given-names>JE</given-names>
</name>
<name>
<surname>Spector</surname> <given-names>TD</given-names>
</name>
<name>
<surname>Bell</surname> <given-names>JT</given-names>
</name>
</person-group>. <article-title>Epigenetics of discordant monozygotic twins: implications for disease</article-title>. <source>Genome Med</source> (<year>2014</year>) <volume>6</volume>:<fpage>60</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13073-014-0060-z</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chunder</surname> <given-names>R</given-names>
</name>
<name>
<surname>Weier</surname> <given-names>A</given-names>
</name>
<name>
<surname>Maurer</surname> <given-names>H</given-names>
</name>
<name>
<surname>Luber</surname> <given-names>N</given-names>
</name>
<name>
<surname>Enders</surname> <given-names>M</given-names>
</name>
<name>
<surname>Luber</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Antibody cross-reactivity between casein and myelin-associated glycoprotein results in central nervous system demyelination</article-title>. <source>Proc Natl Acad Sci U.S.A.</source> (<year>2022</year>) <volume>119</volume>:<fpage>e2117034119</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.2117034119</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodo</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ballester</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cayan</surname> <given-names>D</given-names>
</name>
<name>
<surname>Melish</surname> <given-names>ME</given-names>
</name>
<name>
<surname>Nakamura</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Uehara</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Association of Kawasaki disease with tropospheric wind patterns</article-title>. <source>Sci Rep</source> (<year>2011</year>) <volume>1</volume>:<fpage>152</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep00152</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adler</surname> <given-names>R</given-names>
</name>
<name>
<surname>Boxstein</surname> <given-names>D</given-names>
</name>
<name>
<surname>Schaff</surname> <given-names>P</given-names>
</name>
<name>
<surname>Kelly</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Metallic mercury vapor poisoning simulating mucocutaneous lymph node syndrome</article-title>. <source>J Pediatr</source> (<year>1982</year>) <volume>101</volume>:<page-range>967&#x2013;8</page-range>.</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barbhaiya</surname> <given-names>M</given-names>
</name>
<name>
<surname>Costenbader</surname> <given-names>KH</given-names>
</name>
</person-group>. <article-title>Environmental exposures and the development of systemic lupus erythematosus</article-title>. <source>Curr Opin Rheumatol</source> (<year>2016</year>) <volume>28</volume>:<fpage>497</fpage>&#x2013;<lpage>505</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/BOR.0000000000000318</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stene</surname> <given-names>LC</given-names>
</name>
<name>
<surname>Oikarinen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hyoty</surname> <given-names>H</given-names>
</name>
<name>
<surname>Barriga</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Norris</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Klingensmith</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY)</article-title>. <source>Diabetes</source> (<year>2010</year>) <volume>59</volume>:<page-range>3174&#x2013;80</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.2337/db10-0866</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oikarinen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Martiskainen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tauriainen</surname> <given-names>S</given-names>
</name>
<name>
<surname>Huhtala</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ilonen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Veijola</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Enterovirus RNA in blood is linked to the development of type 1 diabetes</article-title>. <source>Diabetes</source> (<year>2011</year>) <volume>60</volume>:<page-range>276&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.2337/db10-0186</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>